Blog Archives

Drug prices, lost opportunities, and the real cost of healthcare

Last month, the news was flooded (well, mildly soaked at least) with claims that the NHS is paying too much for drugs. My favourite headline was from the Telegraph, which claimed that researchers thought the ‘NHS should stop buying drugs

Posted in Commentary Tagged with: , , , , ,

Ebola screening

What are the arguments over ebola screening really about? Here’s my go at explaining, with a bit of help from the Reverend Bayes.

Posted in Commentary Tagged with: , , , ,

Big Data, Big Knowledge: marketing hype or the future of human understanding?

Data. There’s a lot of it about. If you work in the buzzword driven world of consultancy or large corporations (including the industries of academia and government), you have the dubious pleasure of having it rammed down your throat at

Posted in Commentary Tagged with: , ,

Why are drugs so disappointing?

No, this isn’t an extended post about reefer madness. It’s about that horrible gap between the excitement of a new therapy for an illness, and the results that eventually come out years later. One of my main interests is in

Posted in Commentary Tagged with: ,

Is it worth living? Bill Hicks and smoking cessation

They proved that if you quit smoking, it will prolong your life. What they haven’t proved is that a prolonged life is a good thing. I haven’t seen the stats on that yet. (Bill Hicks, Dark Poet, 1991) So, you’re

Posted in Commentary Tagged with: ,